Enovis Corp (ENOV) — 10-Q Filings

All 10-Q filings from Enovis Corp. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.

10-Q Filings (6)

  • Enovis Plunges to $571M Loss on Massive Goodwill Impairment — Nov 6, 2025 Risk: high
    Enovis Corporation reported a significant net loss of $571.1 million for the three months ended October 3, 2025, a substantial increase from the $31.5 million n
  • Enovis Q2 Earnings Soar 27% on Strong Orthopedic Demand — Aug 7, 2025 Risk: low
    Enovis CORP reported a robust financial performance for the second quarter ended July 4, 2025, with significant growth in revenue and net income. Revenue for th
  • Enovis Corp. Files Q1 2025 10-Q — May 8, 2025 Risk: low
    Enovis Corp. filed its 10-Q for the period ending April 4, 2025. The filing details financial performance and operational updates for the first quarter of 2025.
  • Enovis Corp. Files Q3 2024 10-Q — Nov 6, 2024 Risk: low
    Enovis Corp. filed its 10-Q for the period ending September 27, 2024. The filing details financial performance and operational updates for the company, which op
  • Enovis Corp. Files Q2 2024 10-Q — Aug 7, 2024 Risk: medium
    Enovis Corp. filed its 10-Q for the period ending June 28, 2024. The company, formerly known as Colfax Corp., is a manufacturer of orthopedic, prosthetic, and s
  • Enovis Corp. Files 10-Q for Period Ending March 29, 2024 — May 2, 2024 Risk: low
    Enovis CORP (ENOV) filed a Quarterly Report (10-Q) with the SEC on May 2, 2024. Enovis Corp. filed a 10-Q report for the period ending March 29, 2024. The filin

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.